Provided by Tiger Trade Technology Pte. Ltd.

Lantern Pharma Inc.

0.7107
-0.0263-3.57%
Post-market: 0.71070.00000.00%16:00 EDT
Volume:162.24K
Turnover:116.87K
Market Cap:10.61M
PE:-0.43
High:0.8000
Open:0.7237
Low:0.7000
Close:0.7370
52wk High:4.58
52wk Low:0.7000
Shares:14.94M
Float Shares:12.32M
Volume Ratio:0.61
T/O Rate:1.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6362
EPS(LYR):-1.5709
ROE:-400.92%
ROA:-74.29%
PB:-3.30
PE(LYR):-0.45

Loading ...

Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2024

Major Issues Report

Form 8-K - Current report
Jun 18, 2024

Major Issues Report

Form 8-K - Current report
Jun 07, 2024

Correspondence

Form CORRESP - Correspondence
May 24, 2024

Major Issues Report

Form 8-K - Current report
May 24, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 09, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 18, 2024

Major Issues Report

Form 8-K - Current report
Mar 18, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities